Alex Sapir

CIK 1709415 · See Remarks · last filed 2026-02-04

Alex Sapir is a corporate insider who has filed 12 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing, for FULC, was dated Feb 4, 2026. Across all open-market trades the lifetime net is +$1.3M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $667.1K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$667.1K

Companies

3

Total Filings

12

Lifetime Open-Market Net

$1.33M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
FULC See Remarks 193,360 $3.45 $667.1K $492.0K 4 2026-02-04
PhaseBio Pharmaceuticals Inc (PHAS) Delisted Director $0.07 $0 4 2022-05-20
Dova Pharmaceuticals Inc. (DOVA) Delisted President & CEO 68,609 $837.1K 3 2018-08-15

Recent Filings

12 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-02-04 FULC Grant (A) $0 EDGAR
2025-01-28 FULC Grant (A) $0 EDGAR
2024-07-08 FULC Exer (M) +150,000 $490.5K EDGAR
2024-03-05 FULC Buy (P) +43,360 $492.0K EDGAR
2023-05-19 Exer (M) +3,750 $0
2022-05-20 PhaseBio Pharmaceuticals Inc (PHAS) Delisted Grant (A) $0 EDGAR
2021-06-04 PhaseBio Pharmaceuticals Inc (PHAS) Delisted Grant (A) $0 EDGAR
2020-06-05 PhaseBio Pharmaceuticals Inc (PHAS) Delisted Grant (A) $0 EDGAR
2020-02-14 PhaseBio Pharmaceuticals Inc (PHAS) Delisted Grant (A) $0 EDGAR
2018-08-15 Dova Pharmaceuticals Inc. (DOVA) Delisted Buy (P) +21,700 $495.4K EDGAR
Showing 110 of 12
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.